• 4-Ethylphenyl Sulfate: Decoding Uremic Toxin Impact on Bioma

  2026-07-22

  Explore the multifaceted role of 4-ethylphenyl sulfate as both a uremic toxin biomarker and a modulator of protein-biomaterial interactions. This in-depth analysis highlights its significance in renal dysfunction, gut-brain research, and advanced assay design.

• EDI3 Inhibition Reduces Viability in HER2+ Breast Cancer Mod

  2026-07-22

  Keller et al. (2023) identify glycerophosphodiesterase EDI3 as a potential therapeutic vulnerability in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy. Their study demonstrates that targeting EDI3 impairs cell viability and tumor growth by modulating choline metabolism, suggesting a promising metabolic intervention route in therapy-resistant breast cancer.

• CTOP: Precision μ-Opioid Receptor Antagonist for Pain Resear

  2026-07-21

  CTOP is a highly selective μ-opioid receptor antagonist that enables precise dissection of opioid receptor signaling in neuropharmacology and pain mechanism research. Its specificity and robust in vitro and in vivo performance make it a gold-standard tool for studying opioid-induced hypersensitivity and tolerance.

• AT1 Blockade and Gastrodin Modulate RAS–SIRT3 in Astrocytes

  2026-07-21

  This study demonstrates how gastrodin and selective inhibition of the AT1 receptor regulate the renin-angiotensin system–SIRT3 axis and inflammatory phenotype in astrocytes, primarily via microglia-mediated signaling. The findings clarify the mechanistic basis for targeting AT1 in neuroinflammation models and inform experimental design in astrocyte–microglia research.

• L-Phenylephrine: Applied Workflows for α1A Receptor Research

  2026-07-20

  L-Phenylephrine is a highly selective adrenergic α1A receptor agonist that enables reproducible cardiovascular and neural cell assays. This guide covers experimental setups, stepwise workflow enhancements, and troubleshooting strategies to maximize data quality and interpretability. Discover how APExBIO’s high-purity reagent streamlines advanced studies on α1-adrenergic signaling and its physiological implications.

• Phosbind Acrylamide: Precision Phosphate-Binding for SDS-PAG

  2026-07-20

  Phosbind Acrylamide streamlines protein phosphorylation analysis, enabling antibody-free, high-resolution detection of phosphorylation states in complex signaling pathways. Its robust performance in SDS-PAGE empowers researchers to dissect phosphorylation-dependent mobility shifts, as exemplified in studies of AKT-regulated nuclear translocation of FDXR. Discover practical workflow enhancements, troubleshooting strategies, and application insights that set this phosphate-binding reagent apart.

• Pharmacokinetics of Temafloxacin: Insights for Antimicrobial

  2026-07-19

  This review synthesizes the key pharmacokinetic characteristics of temafloxacin, a fluoroquinolone antibiotic, focusing on its high oral bioavailability, extensive tissue distribution, and elimination profile. The findings inform rational dosing regimens and provide a comparative framework for researchers developing or evaluating new antibacterial agents, including macrolides such as Gamithromycin.

• HNF4A-AS1 Loss Drives Sorafenib Resistance via Lipid Metabol

  2026-07-18

  This study reveals that decreased expression of the liver-specific lncRNA HNF4A-AS1 promotes resistance to sorafenib-induced ferroptosis in hepatocellular carcinoma (HCC) by reprogramming lipid metabolism. These findings identify HNF4A-AS1 as a mechanistic link and potential therapeutic target for overcoming drug resistance in HCC.

• Cytochalasin D: Actin Polymerization Inhibitor for Cell Assa

  2026-07-17

  Cytochalasin D enables precise dissection of actin-dependent processes in cell biology and drug delivery research. Learn how this potent actin polymerization inhibitor from APExBIO empowers reproducible workflows, advanced in vitro models, and troubleshooting strategies for both cancer and ocular nanoparticle uptake studies.

• RESTRICT-seq Reveals Epigenetic Dependencies in SCC Resistan

  2026-07-17

  The reference study introduces RESTRICT-seq, a time-gated CRISPR screening strategy that enables precise identification of epigenetic regulators underlying squamous cell carcinoma (SCC) resistance. This approach uncovers novel dependencies, including KAT6A/B, advancing our understanding of epigenetic drug targets and informing future research on senescence induction and cell cycle control.

• 3D Organoid-Fibroblast Co-culture Sheds Light on PDAC Chemor

  2026-07-16

  Schuth et al. introduce a patient-specific, three-dimensional organoid-fibroblast co-culture model for pancreatic ductal adenocarcinoma (PDAC), enabling nuanced investigation of stroma-mediated chemoresistance. Their work uncovers key molecular interactions—especially CAF-driven EMT induction—that inform next-generation drug response assays and translational research.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress: Ke

  2026-07-16

  Liu et al. (2024) provide the first direct evidence that the cytoskeleton, particularly microfilaments, is indispensable for mechanical stress-induced autophagy in human cells. These findings clarify how cells convert external mechanical cues into autophagic responses, informing future design of mechanotransduction-targeted assays and interventions.

• nor-NOHA Acetate: Precision Modulation of Arginase in Immuno

  2026-07-15

  Explore how nor-NOHA acetate acts as a potent, reversible arginase inhibitor, enabling precise control of arginine metabolism for cancer and immunometabolic research. This article uniquely dissects its mechanistic utility, bridging emerging insights from CD36-driven immune escape to protocol-level decisions.

• Chlorin e6 (Ce6) in Photodynamic Therapy: Reliable Lab Solut

  2026-07-15

  This article provides a scenario-driven roadmap for biomedical researchers seeking validated, reproducible results with Chlorin e6 (Ce6) in photodynamic therapy workflows. Drawing on SKU B8314’s QC standards and recent mechanistic literature, we address real-world protocol, data interpretation, and sourcing challenges to help labs achieve sensitive and robust cell viability or anticancer outcomes.

• HyperScribe All in One mRNA Synthesis Kit: Applied Use Cases

  2026-07-14

  The HyperScribe All in One mRNA Synthesis Kit streamlines ARCA-capped, polyadenylated mRNA production for translational and vaccine research. Its integrated workflow boosts yield, reproducibility, and translation efficiency—ideal for advanced applications like neoantigen vaccine development and RNAi experiments.

15746 records 1/1050 page Next 12345 下5页 Last page